A Simple Assay for Detection of Small-Molecule Redox Activity

Abstract

In addition to selecting molecules of pharmacological interest, high-throughput screening campaigns often generate hits of undesirable mechanism, which cannot be exploited for drug discovery as they lead to obvious problems of specificity and developability. Examples of undesirable mechanisms are target alkylation/acylation and compound aggregation. Both types of “promiscuous” mechanisms have been described in the literature, as have methods for their detection. In addition to these mechanisms, compounds can also inhibit by oxidizing susceptible enzyme targets, such as metalloenzymes and cysteine-using enzymes. However, this redox phenomenon has been documented infrequently, and an easy method for detecting this behavior is missing. In this article, the authors describe direct proof of small-molecule oxidation of a cysteine protease by liquid chromatography/tandem mass spectrometry, develop a simple assay to predict this oxidizing behavior by compounds, and show the utility of this assay by demonstrating its ability to distinguish nuisance redox compounds from well-behaved inhibitors in 3 historical GlaxoSmithKline drug discovery efforts. (Journal of Biomolecular Screening 2007:881-890)

Keywords

cysteine proteases cysteine phosphatases iron enzymes redox cofactors nuisance hits cathepsin L caspase-8

References

Rishton GM : Nonleadlikeness and leadlikeness in biochemical screening. Drug Discov Today 2003;8:86-96.

Schoichet BK : Screening in a spirit haunted world. Drug Discov Today 2006;11:607-615.

Huth JR , Mendoza R. , Olejniczak ET , Johnson RW , Cothron DA , Liu Y. , et al: ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens. J Am Chem Soc 2005;127:217-224.

Copeland RA : Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists. New York: John Wiley, 2005.

McGovern SL , Caselli E. , Grigorieff N. , Shoichet BK : A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 2002;45:1712-1722.

Seidler J. , McGovern SL , Doman TN , Shoichet BK : Identification and prediction of promiscuous aggregating inhibitors among known drugs. J Med Chem 2003;46:4477-4486.

Feng BY , Shelat A. , Doman TN , Guy RK , Shoichet BK : High-throughput assays for promiscuous inhibitors. Nat Chem Biol 2005;1:146-148.

Ryan AJ , Gray NM , Lowe PN , Chung C. : Effect of detergent on “promiscuous” inhibitors. J Med Chem 2003;46:3448-3451.

Kaiserova K. , Srivastava S. , Hoetker JD , Awe SO , Tand XL , Cai J. , et al: Redox activation of aldose reductase in the ischemic heart. J Biol Chem 2006;281:15110-15120.

10.

Seth D. , Rudolph J. : Redox regulation of MAP kinase phosphatase 3. Biochemistry 2006;45:8476-8487.

11.

Smith GK , Barrett DG , Blackburn K. , Cory M. , Dallas WS , Davis R. , et al: Expression, preparation, and high-throughput screening of caspase-8: discovery of redox-based and steroid diacid inhibition. Arch Biochem Biophys 2002;399:195-205.

12.

Percival MD , Ouellet M. , Campagnolo C. , Claveau D. , Li C. : Inhibition of cathepsin K by nitric oxide donors: evidence for formation of mixed disulfides and a sulfenic acid. Biochemistry 1999;38:13574-13583.

13.

Conway ME , Poole LB , Hutson SM : Roles for cysteine residues in the regulatory CXXC motif of human mitochondrial branched chain aminotransferase enzyme. Biochemistry 2004;43:7356-7364.

14.

Sohn J. , Rudolph J. : Catalytic and chemical competence of regulation of Cdc25 by phosphatase by oxidation/reduction. Biochemistry 2003;42: 10060-10070.

15.

Reinheckel T. , Deussing J. , Roth W. , Peters C. : Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L. Biol Chem 2001 ;382:735-741.

16.

Mann M. , Steen H. : The ABC's (and XYZ's) of peptide sequencing. Nat Mol Cell Biol 2004;5:699-711.

17.

Guertin KR , Grimsby J. : Small molecule glucokinase activators as glucose lowering agents: a new paradigm for diabetes therapy. Curr Med Chem 2006;13:1839-1843.

18.

Lal M. , Rao R. , Fang X. , Schuchmann HP , von Sonntag C. : Radical-induced oxidation of dithiothreitol in acidic oxygenated aqueous solution: a chain reaction. J Am Chem Soc 1997;119:5735-5739.

19.

Ballou D. , Palmer G. , Massey V. : Direct demonstration of superoxide anion production during the oxidation of reduced flavin and of its catalytic decomposition by erythrocuprein. Biochem Biophys Res Comm 1969;36:898-904.

20.

Muller F. : Flavin radicals: chemistry and biochemistry. Free Radical Biol Med 1987;3:215-230.

21.

Prutz WA , Butler J. , Land EJ : Photocatalytic and free radical interactions of the heterocyclic N-oxide resazurin with NADH, GSH, and DOPA. Arch Biochem Biophys 1996;327:239-248.

22.

Costas M. , Mehn MP , Jensen MP , Que L. Jr : Dioxygen activation at mononuclear nonheme iron active sites: enzymes, modelas, and intermediates. Chem Rev 2004;104:939-986.

23.

Polgar L. : Mechanisms of Protease Action. Vol. 1. Boca Raton, FL: CRC Press, 1989.

24.

Salmeen A. , Andersen JN , Myers MP , Meng T. , Hinks JA , Tonks NK , et al: Redox regulation of protein tyrosine phosphatase 1B involves a sulphenylamide intermediate. Nature 2003 ;423:769-773.

25.

van Montfort RL , Congreve M. , Tisi D. , Carr R. , Jhotl H. : Oxidation state of the active site cysteine in protein tyrosine phosphatase 1B. Nature 2003;423:773-777.

26.

Bleasdale JE , Ogg D. , Palazuk BJ , Jacob CS , Swanson ML , Wang X. , et al: Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein phosphatase 1B and augment insulin action. Biochemistry 2001;40:5642-5654.

27.

Kivirikko KI , Myllyharju J. : Prolyl 4-hydroxylases and their protein disulfide isomerase subunit. Matrix Biol 1998;16:357-368.